Kyprolis (carfilzomib)
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Kyprolis (carfilzomib), covering 2016-10-31 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma [Phase 2]